A Phase 1 Ascending Single and Multiple Oral Dose Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects, Including a Food Effect Cohort

Trial Profile

A Phase 1 Ascending Single and Multiple Oral Dose Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects, Including a Food Effect Cohort

Discontinued
Phase of Trial: Phase I

Latest Information Update: 20 Oct 2015

At a glance

  • Drugs ASP 7657 (Primary) ; Naproxen
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 26 Mar 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 15 Dec 2014 Planned End Date changed from 1 Feb 2015 to 1 May 2015, according to the ClinicalTrials.gov record.
    • 15 Dec 2014 Planned primary completion date changed from 1 Feb 2015 to 1 May 2015, according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top